Completed
An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes
NCT02911857
- Conditions
- Periodic Fevers Syndrome
- Locations
-
- Novartis Investigative Site Fukuoka, Japan
- Novartis Investigative Site Yokohama, Kanagawa, Japan
- Novartis Investigative Site Kyoto, Japan